Concepedia

Bohumila Fahmy

BF

Statistics

Publications

4

Citations

498

H-Index

4

Active since

1998

Affiliations

Johnson & Johnson (United States)(Current)

Bohumila Fahmy is an author at Johnson & Johnson (United States) specializing in pharmacology, p38 mitogen-activated protein kinase signaling, and medicine.

Publications per year

1998–2006

4

Publications

4

Imidazopyrimidines, potent inhibitors of p38 MAP kinase

Kenneth C. Rupert, James R. Henry, John H. Dodd et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 252 citations · Full text

, , +9

RWJ 67657, a Potent, Orally Active Inhibitor of p38 Mitogen-Activated Protein Kinase

Scott Wadsworth, Druie Cavender, Scott A. Beers et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 158 citations

, , +17

6-Amino-2-(4-fluorophenyl)-4-methoxy-3- (4-pyridyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (RWJ 68354):  A Potent and Selective p38 Kinase Inhibitor

James R. Henry, Kenneth C. Rupert, John H. Dodd et al. · Journal of Medicinal Chemistry · 1998 · 77 citations · Full text

, , +5

Inhibitors of unactivated p38 MAP kinase

James L. Bullington, Dennis Argentieri, Kristin Averill et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 11 citations · Full text

, , +9

1–4 of 4